Milestone Pharmaceuticals (MIST) Operating Income Growth (1y) (2019 - 2022)
Milestone Pharmaceuticals (MIST) Operating Income Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,386.07% |
| 10 | Milestone Pharmaceuticals | 153.61 Mn | -30.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -5.30% |
| Jun 30, 2022 | -2,460.39% |
| Dec 31, 2021 | -93.08% |
| Sep 30, 2021 | -18.11% |
| Jun 30, 2021 | 105.43% |
| Mar 31, 2021 | 24.85% |
| Dec 31, 2020 | 53.62% |
| Sep 30, 2020 | 11.95% |
| Jun 30, 2020 | 8.57% |
| Mar 31, 2020 | -53.32% |
| Dec 31, 2019 | -86.92% |
| Sep 30, 2019 | -137.25% |
| Jun 30, 2019 | -289.93% |
| Mar 31, 2019 | -156.87% |